Related Experiment Video
Updated: Feb 28, 2026

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
Published on: July 5, 2022
Evaluation of polyneuropathy and associated risk factors in children with type 1 diabetes mellitus
Hande Türkyilmaz1, Orkide Güzel1, Selvinaz Edizer1
1Department of Pediatric Neurology, Dr. Behçet Uz Children's Training and Research Hospital, İzmir, Turkey.
Insights
Diabetic neuropathy (DN) affects 22.5% of pediatric diabetes mellitus (DM) patients, with duration and ketoacidosis as key risk factors. Poor metabolic control in early DM stages significantly increases neuropathy risk in children.
Area of Science:
- Pediatric Endocrinology
- Neurology
- Metabolic Diseases
Background:
- Diabetes mellitus (DM) is a prevalent global metabolic disease.
- Diabetic neuropathy (DN) is a chronic complication of DM, rarely reported in children due to its long latency.
- Identifying DN incidence and risk factors in pediatric DM is crucial.
Purpose of the Study:
- To determine the incidence rate of diabetic neuropathy (DN) in pediatric patients with diabetes mellitus (DM).
- To assess the risk factors associated with the development of DN in this population.
Main Methods:
- Retrospective review of data from 111 pediatric DM patients (January 2011 - May 2014).
- Nerve conduction studies (NCS) utilized as the gold standard for DN diagnosis.
- Linear regression analysis applied to identify correlations with DN presence.
Main Results:
- Symptomatic DN incidence was 13.5%; EMG-diagnosed DN incidence was 22.5%.
- Positive correlations identified between diabetes duration, diabetic ketoacidosis history, and DN.
- Poor metabolic control, particularly early in the disease, emerged as a significant risk factor.
Conclusions:
- Poor metabolic control in early pediatric DM is a primary risk factor for neuropathy.
- Long-term prospective studies evaluating nerve conduction in children with DM are recommended.
- This research highlights the importance of early intervention and management in preventing pediatric DN.
Background/Aim:
Diabetes mellitus (DM) is one of the most common metabolic diseases seen in the world today. Diabetic neuropathy (DN) is a chronic complication of the disease that is rarely reported in children, since it has a relatively longer latency period. Our main objective in this study is to determine the incidence rate of DN in pediatric DM patients and assess the risk factors associated with DN.
Materials And Methods:
Data from 111 patients from January 2011 to May 2014 were reviewed in a retrospective manner. Nerve conduction studies were performed as the gold standard in diagnosis.
Results:
The incidence rate of symptomatic DN was 13.5% according to our study results. The EMG-diagnosed DN incidence rate was calculated as 22.5%. Following linear regression analysis, positive correlation was found between diabetes duration, diabetic ketoacidosis, and DN presence.
Conclusion:
Our study results demonstrate the fact that poor metabolic control, especially during early stages of the disease, is a major risk factor for neuropathy development. Planning prospective studies with long-term evaluations on nerve conduction in children with DM will be beneficial for this subject.
Related Concept Videos
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes Mellitus: Type 2 and Gestational
Diabetes: Symptoms, Diagnosis, and Complications
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Psychoneuroimmunology: Diabetes and Cancer

